SBIR/STTR Research Award

DNA Isolation and Amplification

Award identifier 8464560e6e75c8f86ea25b30225c8f22010f652d0305660e37d0b2693bf0f6b0Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$99,810

Program and phase

SBIR · Phase I

Award year

2001

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
PRECISION RESEARCH, INC.
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

Precision Research, Inc. will develop an improved method and associated hardware to isolate and amplify nucleic acid sequences. Nucleic acid sequencing, analysis, and amplification is a large growing research tool for genetic and microbial scientists. Commercialization opportunities in genomics, molecular biology, diagnostics, gene therapy, environmental control, pharmacogenomics, proteomics, etc. are all in their infancy. Although basic techniques in isolation and sequencing have advanced rapidly, improvements are still needed in automating techniques for purification and amplification of target sequences. Precision Research will provide a new integrated method, which will both improve the isolation of target sequences and the efficiency of PCR amplification of these sequences. Along with the method, Precision Research will develop all hardware and software for a prototype which will automate the isolation and amplification method in a manner that will also provide for containment of the steps to minimize contamination. The initial opportunity will focus on the current marketplace needs for research in genomics and molecular biology. Integration of automated analytical capabilities with associated probes, will provide secondary market opportunities m diagnostics. Advancement of this technology will also lead to improved efficiency in scale-up models, which is required in environmental control and proteomic applications. PROPOSED COMMERCIAL APPLICATIONS: This research will provide improve methodologies, materials, an instrumentation to advance the efficiencies and scale-up of nucleic acid sequencing research. Opportunities exist in genomic and molecular biology research, diagnostics, environmental control, and proteomics. There will a need for production quantities of this type of reagent in the near future. This method may be able to meet this need.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.